Prostate- and metastases-directed radiotherapy in de novo low-volume metastatic prostate cancer

Background: The role of radiotherapy in de novo low-volume metastatic prostate cancer (LVmPC) is constantly evolving and still offers considerable potential for further optimization. Rising interest in this topic demands further investigations in this specific patient cohort. We report on clinical o...

Descripció completa

Dades bibliogràfiques

Autors principals:	Jan-Hendrik Bolten, Fabian Weykamp, Christoph Grott, David Neugebauer, Lars Wessel, Felix H. Englert, Justus Valentini, Magdalena Goertz, Stephanie Zschaebitz, Johannes Huber, Erik Winter, Juergen Debus, Jakob Liermann
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2026-01-01
Col·lecció:	Clinical and Translational Radiation Oncology
Matèries:	Excellent tolerability of ablative radiotherapy of all PSMA-PET positive tumor manifestations in low-volume disease of oligometastatic prostate cancer Importance of PSMA-PET-Staging in oligometastatic prostate cancer Further stratification in low volume disease of oligometastatic prostate cancer is needed
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2405630825001648
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!